IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 130 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15 | -92.5% | 8,883 | -91.9% | 0.00% | – |
| Q1 2023 | $199 | +1890.0% | 109,766 | +5415.9% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 1,990 | -96.4% | 0.00% | – |
| Q3 2022 | $274,000 | +81.5% | 55,252 | +35.2% | 0.00% | – |
| Q2 2022 | $151,000 | +11.9% | 40,852 | +69.3% | 0.00% | – |
| Q1 2022 | $135,000 | -72.4% | 24,136 | -70.0% | 0.00% | – |
| Q4 2021 | $489,000 | +940.4% | 80,448 | +2308.6% | 0.00% | – |
| Q3 2021 | $47,000 | +14.6% | 3,340 | +15.5% | 0.00% | – |
| Q2 2021 | $41,000 | -95.6% | 2,891 | -92.7% | 0.00% | -100.0% |
| Q1 2021 | $936,000 | – | 39,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 251,556 | $1,387,000 | 1.70% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,322 | $1,567,000 | 0.89% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,668,000 | 0.54% |
| ALLEN HOLDING INC /NY | 687,571 | $3,417,000 | 0.54% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $479,000 | 0.21% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $1,033,000 | 0.17% |
| Clearwater Capital Advisors, LLC | 185,911 | $924,000 | 0.13% |
| WEALTH EFFECTS LLC | 28,500 | $142,000 | 0.09% |
| Virtus ETF Advisers LLC | 35,048 | $174,000 | 0.07% |
| Vident Investment Advisory, LLC | 195,127 | $969,000 | 0.03% |